| Reference | Experiment Type | Cell/Tissue/Microbe/Strain | Test Organism | Lifestage | Administration Method | Target Organism | Administered Dose Range | Significant Dose Range | Time to Death of Pathogen (min) | Anthelminthic Efficacy (%) | Therapeutic Action |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PMID:30179290 | In vitro | SY-AJ | - | - | - | Acinetobacter johnsonii | 10.0 μg |
10.0 μg |
- | - | Antibacterial |
| In vitro | SY-AS1 | - | - | - | Aeromonas sobria | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-AS3 | - | - | - | Aeromonas sobria | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-AV10 | - | - | - | Aeromonas veronii | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-BN9 | - | - | - | Bacillus nealsonii | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-BP15 | - | - | - | Bacillus pumilus | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-AH2 | - | - | - | Aeromonas hydrophila | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-BS19 | - | - | - | Bacillus subtilis | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-BT11 | - | - | - | Bacillus thuringiensis | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-CF14 | - | - | - | Citrobacter freundii | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-EC4 | - | - | - | Escherichia coli | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-ED1 | - | - | - | Edwardsiella tarda | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-ED14 | - | - | - | Edwardsiella tarda | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-EN560 | - | - | - | Enterobacter sp. | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-BS20 | - | - | - | Bacillus subtilis | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-KP1 | - | - | - | Klebsiella pneumoniae | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | E42 | - | - | - | Yersinia ruckeri | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | ATCC 6633 | - | - | - | Bacillus subtilis | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | BC7321 | - | - | - | Lactobacillus plantarum | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | ATCC 25922 | - | - | - | Escherichia coli | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | ATCC 33658 | - | - | - | Aeromonas salmonicida | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-L24 | - | - | - | Vibrio (Listonella) anguillarum | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-LA18 | - | - | - | Lelliottia amnigena | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-LG1 | - | - | - | Lactococcus garvieae | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-LX12 | - | - | - | Lysinibacillus xylanilyticus | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-PP21 | - | - | - | Pseudomonas putida | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-PS16 | - | - | - | Plesiomonas shigelloides | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-S145 | - | - | - | Shewanella baltica | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| In vitro | SY-VC10 | - | - | - | Vibrio crassostreae | 10.0 μg |
10.0 μg |
- | - | Antibacterial | |
| PMID:36265741 | In vitro | Ah-315 | - | - | - | Aeromonas hydrophila | 1.0 mg/mL |
1.0 mg/mL |
- | - | Antibacterial |
| In vitro | Bacteria | - | - | - | Vibrio parahaemolyticus | 1.0 mg/mL |
1.0 mg/mL |
- | - | Antibacterial | |
| PMID:37970451 | In vitro | - | - | - | - | Klebsiella pneumoniae | 64.0-128.0 μg/mL |
64.0-128.0 μg/mL |
- | - | Antibacterial |
ReCAnt is a database of chemicals used in aquaculture and their ecotoxic effects, compiled from published literature. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on chemicals used in aquaculture is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.